Characteristics of rare ST463 carbapenem-resistant Pseudomonas aeruginosa clinical isolates from blood

被引:4
|
作者
Zhang, Xiaodong [1 ]
Tang, Miran [1 ]
Xu, Ye [2 ]
Xu, Mengxin [1 ]
Qian, Changrui [3 ]
Zheng, Xiangkuo [1 ]
Zhou, Tieli [1 ,4 ]
Wu, Qing [1 ,4 ]
机构
[1] Wenzhou Med Univ, Dept Clin Lab, Key Lab Clin Lab Diag & Translat Res Zhejiang Prov, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Southern Med Univ, Affiliated Hosp 5, Dept Clin Lab, Guangzhou, Peoples R China
[3] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou, Peoples R China
[4] Wenzhou Med Univ, Dept Clin, Key Lab Clin Lab Diag & Translat Res Zhejiang Prov, Affiliated Hosp 1, Wenzhou 325000, Peoples R China
关键词
bla KPC-2; bla OXA-486; Carbapenem-resistant Pseudomonas  aeruginosa; crpP; ST463; Virulence;
D O I
10.1016/j.jgar.2023.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aimed to elucidate resistance to carbapenems and fluoroquinolones, the transmis-sion mechanism of blaKPC-2, and the virulence characteristics of a Pseudomonas aeruginosa strain (TL3773) isolated in East China.Methods: The virulence and resistance mechanisms of TL3773 were investigated by whole genome se-quencing (WGS), comparative genomic analysis, conjugation experiments, and virulence assays. Results: This study isolated carbapenem-resistant P. aeruginosa from blood resistant to carbapen-ems. The patient's clinical data showed poor prognosis compounded by multiple sites of infec-tion. WGS showed that TL3773 carried aph (3')-IIb, blaPAO, bla OXA-486, fosA, catB7, and two crpP re-sistance genes on chromosome, and the carbapenem resistance gene blaKPC-2 on plasmid. We iden-tified a novel crpP gene named TL3773-crpP2. Cloning experiments proved that TL3773-crpP2 was not the primary cause of fluoroquinolone resistance in TL3773. GyrA and ParC mutations may con-fer fluoroquinolone resistance. The blaKPC-2 genetic environment was IS26-TnpR-ISKpn27- blaKPC-2-ISKpn6- IS26-Tn3-IS26, potentially mediating the transmission of blaKPC-2 in P. aeruginosa. The overall vir-ulence of TL3773 was lower than that of PAO1. However, the pyocyanin and biofilm formation of TL3773 was higher than that of PAO1. WGS further indicated that TL3773 was less virulent than PAO1. Phylogenetic analysis showed that TL3773 was most similar to the P. aeruginosa isolate ZYPA29 from Hangzhou, China. These observations further indicate that ST463 P. aeruginosa is rapidly spreading.Conclusions: The threat of ST463 P. aeruginosa harbouring blaKPC-2 is emergent and may pose a threat to human health. More extensive surveillance and effective actions are urgently needed to control its further spread.(c) 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:122 / 130
页数:9
相关论文
共 50 条
  • [1] Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain
    Tu, Yuexing
    Wang, Dairong
    Zhu, Yiwei
    Li, Jiayan
    Jiang, Yan
    Wu, Wenhao
    Li, Xi
    Zhou, Hua
    MICROBIOLOGY SPECTRUM, 2022, 10 (01):
  • [2] Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal
    Takahashi, Toshihiro
    Tada, Tatsuya
    Shrestha, Shovita
    Hishinuma, Tomomi
    Sherchan, Jatan B.
    Tohya, Mari
    Kirikae, Teruo
    Sherchand, Jeevan B.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 279 - 284
  • [3] Molecular epidemiological characteristics of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in southeast Shanxi, China
    Bai, Yang
    Gong, Yan-e
    Shen, Fangfang
    Li, Hui
    Cheng, Yan
    Guo, Jinying
    Liu, Guangming
    Ji, Ai -fang
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 301 - 306
  • [4] Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates
    Tanriverdi Cayci, Yeliz
    Cirit, Osman Sezer
    Biyik, Ilknur
    Cinar, Canberk
    Gur Vural, Demet
    Bilgin, Kemal
    Birinci, Asuman
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2022, 11
  • [5] Susceptibility of carbapenem-resistant Pseudomonas aeruginosa clinical isolates to novel cephalosporine antibiotics
    Geraldy, Philipp
    Krause, Robert
    Zollner-Schwetz, Ines
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S126 - S126
  • [6] Carbapenem-Resistant Pseudomonas aeruginosa
    Eraksoy, Haluk
    KLIMIK JOURNAL, 2014, 27 (02) : 37 - 37
  • [7] Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates
    Kunakonvichaya, Benjaporn
    Thirapanmethee, Krit
    Khuntayaporn, Piyatip
    Montakantikul, Preecha
    Chomnawang, Mullika Traidej
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 (05) : 556 - 557
  • [8] Molecular Analysis of Antibiotic Resistance in Carbapenem-Resistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples
    Altan, Gulsah
    Rakici, Erva
    Ozgumus, Osman Birol
    MIKROBIYOLOJI BULTENI, 2024, 58 (02): : 148 - 170
  • [9] Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates
    Chen, Yili
    Xiang, Guoxiu
    Liu, Pingjuan
    Zhou, Xianling
    Guo, Penghao
    Wu, Zhongwen
    Yang, Juhua
    Chen, Peisong
    Huang, Junqi
    Liao, Kang
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 276 - 283
  • [10] Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
    Skalweit, Marion J.
    Li, Mei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3013 - 3020